Purple Innovation receives Nasdaq delisting determination; will appeal by May 12

Purple Innovation, Inc.

• Nasdaq notified Purple on May 5, 2026 that it failed to regain compliance with the $1.00 minimum bid price rule.
• Cure period ended May 4, 2026; company not eligible for a second 180-day period.
• Delisting scheduled for May 14, 2026 unless appeal is requested by May 12, 2026.
• Company plans to appeal and request a hearing before the Nasdaq Hearings Panel.
• Expects stock to trade pending hearing; plans to effect a reverse stock split to regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.